Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Chomienne

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Blood|November 20, 2012
JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathwayMaria De Grandis, Marie Cambot, Marie-Paule Wautier, et al.
British Journal of Haematology|May 29, 2010
Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher diseaseJuliette Berger, Séverine Lecourt, Valérie Vanneaux, et al.
Molecular Pharmacology|July 16, 2021
The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3)Jérémy Berthelet, Christina Michail, Linh-Chi Bui, et al.
Free Radical Biology & Medicine|December 5, 2020
Human CREBBP acetyltransferase is impaired by etoposide quinone, an oxidative and leukemogenic metabolite of the anticancer drug etoposide through modification of redox-sensitive zinc-finger cysteine residuesWenchao Zhang, Jérémy Berthelet, Christina Michail, et al.
Blood|February 14, 2004
Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia RegisterChristine Bellanné-Chantelot, Séverine Clauin, Thierry Leblanc, et al.
Stem Cells and Development|July 4, 2009
Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patientsSéverine Lecourt, Valérie Vanneaux, Thierry Leblanc, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of <sup>18</sup>F-FLT PETLaetitia Vercellino, Matthieu John Ouvrier, Emmanuelle Barré, et al.
The Journal of Biological Chemistry|June 29, 2019
Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signalingRomain Duval, Linh-Chi Bui, Cécile Mathieu, et al.
Cancers|April 23, 2020
Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative NeoplasmsDorothée Faille, Lamia Lamrani, Stéphane Loyau, et al.
Plos One|August 13, 2013
A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patientsSéverine Lecourt, Enguerran Mouly, Delphine Freida, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Blood|November 20, 2012
JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathwayMaria De Grandis, Marie Cambot, Marie-Paule Wautier, et al.
British Journal of Haematology|May 29, 2010
Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher diseaseJuliette Berger, Séverine Lecourt, Valérie Vanneaux, et al.
Molecular Pharmacology|July 16, 2021
The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3)Jérémy Berthelet, Christina Michail, Linh-Chi Bui, et al.
Free Radical Biology & Medicine|December 5, 2020
Human CREBBP acetyltransferase is impaired by etoposide quinone, an oxidative and leukemogenic metabolite of the anticancer drug etoposide through modification of redox-sensitive zinc-finger cysteine residuesWenchao Zhang, Jérémy Berthelet, Christina Michail, et al.
Blood|February 14, 2004
Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia RegisterChristine Bellanné-Chantelot, Séverine Clauin, Thierry Leblanc, et al.
Stem Cells and Development|July 4, 2009
Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patientsSéverine Lecourt, Valérie Vanneaux, Thierry Leblanc, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2017
Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of <sup>18</sup>F-FLT PETLaetitia Vercellino, Matthieu John Ouvrier, Emmanuelle Barré, et al.
The Journal of Biological Chemistry|June 29, 2019
Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signalingRomain Duval, Linh-Chi Bui, Cécile Mathieu, et al.
Cancers|April 23, 2020
Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative NeoplasmsDorothée Faille, Lamia Lamrani, Stéphane Loyau, et al.
Plos One|August 13, 2013
A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patientsSéverine Lecourt, Enguerran Mouly, Delphine Freida, et al.
Pageof 11